TYK Medicines-B (02410) announced the completion of its H share full circulation process on March 4, 2026. According to the announcement, 4.61 million unlisted shares were successfully converted into H shares, and the newly converted shares will begin listing on the Hong Kong Stock Exchange at 9:00 a.m. on March 5, 2026.

Before this conversion, TYK Medicines-B (02410) had 375.46 million H shares (98.79% of total share capital) and 4.61 million unlisted shares (1.21%). Upon completion, TYK Medicines-B (02410) now has a total of 380.07 million H shares, representing 100.00% of its share capital. The announcement advises shareholders and potential investors to exercise caution when dealing in its H shares.